Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling

International Journal of Biochemistry and Cell Biology

Volumn 61, Issue , 2015, Pages 120-128

  Xu, Ya Fei ^a   Li, Ying Qin ^a   Guo, Rui ^a   He, Qing Mei ^a   Ren, Xian Yue ^a   Tang, Xin Ran ^a   Jia, Wei Hua ^a   Kang, Tie Bang ^a   Zeng, Mu Sheng ^a   Sun, Ying ^a   Ma, Jun ^a   Liu, Na ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

KRAS; miR 143; Nasopharyngeal carcinoma; Signalling pathway; Tumour growth

Indexed keywords

MICRORNA 143; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; KRAS PROTEIN, HUMAN; MICRORNA; MIRN143 MICRORNA, HUMAN; ONCOPROTEIN; PARAFFIN; RAS PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION; GAP JUNCTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; ONCOGENE K RAS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL GROWTH; CELL SURVIVAL; GENETIC TRANSFECTION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; ONCOGENE RAS; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CASE-CONTROL STUDIES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; GENES, RAS; GENES, TUMOR SUPPRESSOR; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84923652421     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.02.006     Document Type: Article

References (32)

1. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
2. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
3. H.C. Chen, G.H. Chen, Y.H. Chen, W.L. Liao, C.Y. Liu, and K.P. Chang MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma Br J Cancer 100 2009 1002 1011
4. X. Chen, X. Guo, H. Zhang, Y. Xiang, J. Chen, and Y. Yin Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 2009 1385 1392
5. C. Clape, V. Fritz, C. Henriquet, F. Apparailly, P.L. Fernandez, and F. Iborra miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice PLoS ONE 4 2009 e7542
6. L. Dou, D. Zheng, J. Li, Y. Li, L. Gao, and L. Wang Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression Oncogene 31 2012 507 517
7. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
8. L.H. Gregersen, A. Jacobsen, L.B. Frankel, J. Wen, A. Krogh, and A.H. Lund MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells BMC Cancer 12 2012 232
9. H. Guo, Y. Chen, X. Hu, G. Qian, S. Ge, and J. Zhang The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells Mol Cancer 12 2013 77
10. M. Guttman, and J.L. Rinn Modular regulatory principles of large non-coding RNAs Nature 482 2012 339 346
11. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 2004 522 531
12. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, and S. Goodson A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833
13. S. Hyun, J.H. Lee, H. Jin, J. Nam, B. Namkoong, and G. Lee Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K Cell 139 2009 1096 1108
14. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
15. Y. Kitade, and Y. Akao MicroRNAs and their therapeutic potential for human diseases: miRNAs, miR-143 and miR-145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drug J Pharmacol Sci 114 2010 276 280
16. T. Korbler, M. Grskovic, M. Dominis, and M. Antica A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tissues Exp Mol Pathol 74 2003 336 340
17. O. Kranenburg The KRAS oncogene: past, present, and future Biochim Biophys Acta 1756 2005 81 82
18. S.Z. Lai, W.F. Li, L. Chen, W. Luo, Y.Y. Chen, and L.Z. Liu How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients Int J Radiat Oncol Biol Phys 80 2011 661 668
19. N. Liu, N.Y. Chen, R.X. Cui, W.F. Li, Y. Li, and R.R. Wei Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis Lancet Oncol 13 2012 633 641
20. N. Liu, N. Jiang, R. Guo, W. Jiang, Q.M. He, and Y.F. Xu MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma Mol Cancer 12 2013 123
21. N. Liu, L.L. Tang, Y. Sun, R.X. Cui, H.Y. Wang, and B.J. Huang MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma Cancer Lett 329 2013 181 188
22. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
23. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, and D. Peck MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
24. J. Lu, M.L. He, L. Wang, Y. Chen, X. Liu, and Q. Dong MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 Cancer Res 71 2011 225 233
25. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
26. Y.Y. Mo, and W.T. Beck Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity Exp Cell Res 252 1999 50 62
27. E.K. Ng, W.P. Tsang, S.S. Ng, H.C. Jin, J. Yu, and J.J. Li MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer Br J Cancer 101 2009 699 706
28. S. Sengupta, J.A. den Boon, I.H. Chen, M.A. Newton, S.A. Stanhope, and Y.J. Cheng MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins Proc Natl Acad Sci USA 105 2008 5874 5878
29. S. Valastyan, F. Reinhardt, N. Benaich, D. Calogrias, A.M. Szasz, and Z.C. Wang A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Cell 137 2009 1032 1046
30. H.Y. Wang, M. Luo, I.V. Tereshchenko, D.M. Frikker, X. Cui, and J.Y. Li A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome Genome Res 15 2005 276 283
31. H. Xia, W.K. Cheung, J. Sze, G. Lu, S. Jiang, and H. Yao miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling J Biol Chem 285 2010 36995 37004
32. C. Yi, Q. Wang, L. Wang, Y. Huang, L. Li, and L. Liu MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma Oncogene 31 2012 4421 4433